Drugs & Targets Opdivo gets FDA accelerated approval for MSI-H/dMMR colorectal cancer August 04, 2017Vol.43 No.31
Drugs & Targets Amgen, Allergan submit biosimilar application for ABP 980 to FDA August 04, 2017Vol.43 No.31
Drugs & Targets Kite files the first CAR-T application in Europe for axicabtagene ciloleucel August 04, 2017Vol.43 No.31
Drugs & Targets BMS to acquire IFM Therapeutics to focus on innate immunity August 04, 2017Vol.43 No.31
Drugs & Targets BMS, Clovis form collaboration to evaluate Opdivo and Rubraca August 04, 2017Vol.43 No.31
Drugs & Targets Loxo Oncology acquires highly selective, reversible BTK inhibitor August 04, 2017Vol.43 No.31
Drugs & Targets MedStar Health partners with Indivumed to advance precision oncology research August 04, 2017Vol.43 No.31
Drugs & Targets FDA approves treatment to reduce risk of breast cancer returning August 03, 2017Vol.40 No.07
Drugs & Targets CHMP issues positive opinion for avelumab for metastatic Merkel cell carcinoma July 28, 2017Vol.43 No.30
